Join now & save up to 80% on medication

JOIN NOW
Select Language:

Join now and save 80% on medication

Register/Login

Onglyza (Saxagliptin) 2.5mg, 5mg Side Effects

Share Post:

Onglyza (Saxagliptin) Side Effects

The possible side effects of the drug are:

  • Upper respiratory tract infection
  • Urinary tract infection
  • Headache
  • Runny nose
  • Sore throat
  • Cough

The above Onglyza side effects are normally mild and clear after the body become used to the drug. If they are more serious or don’t go way, consult the pharmacist or the physician. As for the severe side effects, contact the medical care provider; if the signs are fatal or if you think you are experiencing a medical emergency.

Such negative effects include:

  • Pancreatitis
  • Allergic reactions
  • Fevers and chills
  • Painful urination
  • Swelling of the ankles, feet, and hands
  • Unusual abdominal pain
  • Vomiting
  • Reduction of white blood cells levels
  • Heart failure

The use of the drug hasn’t been established while one is pregnant. It’s recommended to avoid taking the drug during pregnancy unless considered important by the physician. Saxagliptin side effects are almost similar to other medicines which fall under the category of DPP-4 inhibitors like Januvia and Tradjenta.

In Conclusion

Anyone is at risk of unwanted effects if the drug is not taken as directed or prescribed. If a patient takes it in skipped doses or do not take it all, the blood glucose will get high and diabetes may worsen. Taking an overdose may trigger low blood sugar, thus follow the doctor’s prescription.

Doctor’s Recommendation

DPP4 inhibitors have less efficacy than GLP-1 agonists. However, they may be good additions for individuals with renal impairment who need additional glucose reduction despite being on other glucose-lowering medications.

Disclaimer: Please note that the contents of this community article are strictly for informational purposes and should not be considered as medical advice. This article, and other community articles, are not written or reviewed for medical validity by Canadian Insulin or its staff. All views and opinions expressed by the contributing authors are not endorsed by Canadian Insulin. Always consult a medical professional for medical advice, diagnosis, and treatment.

Medically Reviewed

Profile image of Dr Pawel Zawadzki

Medically Reviewed By Dr Pawel ZawadzkiDr. Pawel Zawadzki, a U.S.-licensed MD from McMaster University and Poznan Medical School, specializes in family medicine, advocates for healthy living, and enjoys outdoor activities, reflecting his holistic approach to health.

Profile image of CDI Staff Writer

Written by CDI Staff WriterOur internal team are experts in many subjects. on April 20, 2021

Related Products

Related Articles

Diabetes, General Health,
Probiotics and Type 2 Diabetes: A Promising Partnership for Better Health

Discover how probiotics may help manage Type 2 Diabetes Mellitus and improve your overall well-being.Type 2 Diabetes Mellitus (T2DM) is a chronic condition affecting millions worldwide. Characterized by high blood…

Read More
Diabetes, Diabetes Supplies,
Metformin: Combating Inflammation in Multiple Organ Systems-An Overview

Discover how a common diabetes medication is showing promise against inflammation-driven diseases.Introduction: More Than Just a Diabetes DrugMetformin, a medication that has been prescribed for over 50 years, is widely…

Read More
Cardiovascular Health, Diabetes,
New Data Proving Metformin is Healthy for the Heart in People with Type 2 Diabetes

Type 2 diabetes mellitus (T2DM) affects millions of people worldwide and significantly increases the risk of heart disease. While managing blood sugar levels is crucial, recent research suggests that some…

Read More
Diabetes, Diabetes Supplies,
Pioglitazone: A Promising Ally Against Sepsis in Type 2 Diabetes Patients

Understanding Sepsis and Its Impact on Diabetic PatientsSepsis is a life-threatening condition that arises when the body’s response to infection causes injury to its own tissues and organs. It’s a…

Read More